Devyser Diagnostics Overview
- Year Founded
-
2004
- Status
-
Public
- Employees
-
110
- Stock Symbol
-
DVYSR
- Investments
-
3
- Share Price
-
$6.54
- (As of Friday Closing)
Devyser Diagnostics General Information
Description
Devyser Diagnostics AB is engaged in the development, manufacture, and sale of kits for genetic testing in routine diagnostic laboratories. The products are used for genetic testing in the hereditary disease, oncology, and transplant fields, to enable targeted cancer treatment, the diagnosis of a large number of genetic diseases, and transplant patient follow-up.
Contact Information
Website
www.devyser.comCorporate Office
- Branningevagen 12
- 120 54 Arsta
- Sweden
Corporate Office
- Branningevagen 12
- 120 54 Arsta
- Sweden
Devyser Diagnostics Stock Performance
As of 13-Nov-2026, Devyser Diagnostics’s stock price is $6.54. Its current market cap is $110M with 16.9M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $6.54 | $6.52 | $4.86 - $12.96 | $110M | 16.9M | 18.7K | $0.16 |
Devyser Diagnostics Financials Summary
As of 30-Sep-2026, Devyser Diagnostics has a trailing 12-month revenue of $27M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 82,312 | 203,404 | 167,742 | 106,681 |
| Revenue | 27,000 | 25,497 | 20,509 | 15,928 |
| EBITDA | 6,151 | 2,707 | (2,893) | (4,281) |
| Net Income | 2,703 | (855) | (5,815) | (5,043) |
| Total Assets | 49,519 | 51,044 | 42,942 | 51,041 |
| Total Debt | 4,402 | 5,640 | 5,356 | 7,485 |
Devyser Diagnostics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Devyser Diagnostics Patents
Devyser Diagnostics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3408408-A1 | Selective amplification of desired nucleic acid regions in a target sequence | Active | 27-Jan-2016 | ||
| US-10246740-B2 | Selective amplification of desired nucleic acid regions in a target sequence | Active | 27-Jan-2016 | ||
| US-20180371528-A1 | Selective amplification of desired nucleic acid regions in a target sequence | Active | 27-Jan-2016 | ||
| WO-2017129756-A1 | Selective amplification of desired nucleic acid regions in a target sequence | Inactive | 27-Jan-2016 | ||
| EP-3408408-B1 | Selective amplification of desired nucleic acid regions in a target sequence. | Active | 27-Jan-2016 | C12Q1/686 |
Devyser Diagnostics Signals
Devyser Diagnostics Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Devyser Diagnostics Investments & Acquisitions (3)
Devyser Diagnostics’s most recent deal was a Merger/Acquisition with CyberGene for . The deal was made on 01-Apr-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| CyberGene | 01-Apr-2026 | Merger/Acquisition | Diagnostic Equipment | ||
| SmartSeq | 04-Feb-2022 | Merger/Acquisition | Decision/Risk Analysis | ||
| SmartSeq | 01-Dec-2018 | Secondary Transaction - Private | Decision/Risk Analysis |
Devyser Diagnostics ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Healthcare
Industry
Rank
Percentile
Medical Devices
Subindustry
Rank
Percentile
Devyser Diagnostics Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| SmartSeq | Alessandria, Italy | 2013 | |
| CyberGene | Solna, Sweden | 1995 |
Devyser Diagnostics FAQs
-
When was Devyser Diagnostics founded?
Devyser Diagnostics was founded in 2004.
-
Where is Devyser Diagnostics headquartered?
Devyser Diagnostics is headquartered in Arsta, Sweden.
-
What is the size of Devyser Diagnostics?
Devyser Diagnostics has 110 total employees.
-
What industry is Devyser Diagnostics in?
Devyser Diagnostics’s primary industry is Diagnostic Equipment.
-
Is Devyser Diagnostics a private or public company?
Devyser Diagnostics is a Public company.
-
What is Devyser Diagnostics’s stock symbol?
The ticker symbol for Devyser Diagnostics is DVYSR.
-
What is the current stock price of Devyser Diagnostics?
As of 13-Nov-2026 the stock price of Devyser Diagnostics is $6.54.
-
What is the current market cap of Devyser Diagnostics?
The current market capitalization of Devyser Diagnostics is $110M.
-
What is Devyser Diagnostics’s current revenue?
The trailing twelve month revenue for Devyser Diagnostics is $27M.
-
What is Devyser Diagnostics’s annual earnings per share (EPS)?
Devyser Diagnostics’s EPS for 12 months was $0.16.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process